The prognostic associations of FOXP3+ TILs could be affected by tumor microenvironment, including tumor site, histologic and molecular subtype, and different types of immune response, all of which may interactively influence clinical outcome of cancer patients. This evidence concerns the gene FOXP3 and cancer.